Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$524M |
| 2 |
Peloton Interactive
PTON
|
+$465M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$290M |
| 5 |
Snap
SNAP
|
+$262M |
Top Sells
| 1 |
Zoom
ZM
|
+$965M |
| 2 |
Pinduoduo
PDD
|
+$805M |
| 3 |
AbbVie
ABBV
|
+$794M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$757M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$750M |
Sector Composition
| 1 | Healthcare | 20.82% |
| 2 | Technology | 16.68% |
| 3 | Consumer Discretionary | 11.18% |
| 4 | Communication Services | 10.87% |
| 5 | Consumer Staples | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVLP
1701
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $4.22M | ﹤0.01% |
1,023,207
+29,000
| +3% | +$119K |
|
|
OMCC
1702
Old Market Capital Corporation Common Stock
OMCC
$35.2M
| $4.2M | ﹤0.01% |
501,350
+8,607
| +2% | +$72.1K |
|
1703
Neuronetics
STIM
$207M
| $4.2M | ﹤0.01% |
377,961
-48,600
| -11% | -$540K |
|
1704
First Business Financial Services
FBIZ
$431M
| $4.2M | ﹤0.01% |
227,965
+8,300
| +4% | +$153K |
|
1705
Everest Group
EG
$14.7B
| $4.19M | ﹤0.01% |
17,900
-55,900
| -76% | -$13.1M |
|
1706
Bankwell Financial Group
BWFG
$359M
| $4.17M | ﹤0.01% |
213,500
+19,200
| +10% | +$375K |
|
1707
DLH Holdings
DLHC
$79.1M
| $4.16M | ﹤0.01% |
446,268
-16,062
| -3% | -$150K |
|
|
AGTC
1708
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $4.16M | ﹤0.01% |
1,016,840
-52,800
| -5% | -$216K |
|
|
TPTX
1709
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $4.16M | ﹤0.01% |
34,100
-63,000
| -65% | -$7.68M |
|
|
ABB
1710
DELISTED
ABB Ltd.
ABB
| $4.15M | ﹤0.01% |
148,500
-120,800
| -45% | -$3.38M |
|
1711
SIGA Technologies
SIGA
$639M
| $4.14M | ﹤0.01% |
569,314
-6,500
| -1% | -$47.3K |
|
1712
Franklin Electric
FELE
$4.21B
| $4.12M | ﹤0.01% |
59,500
+7,100
| +14% | +$491K |
|
1713
Essent Group
ESNT
$6.29B
| $4.11M | ﹤0.01% |
95,190
-9,910
| -9% | -$428K |
|
1714
VanEck Semiconductor ETF
SMH
$28.8B
| $4.11M | ﹤0.01% |
+37,600
| New | +$4.11M |
|
1715
Equity Residential
EQR
$25.4B
| $4.1M | ﹤0.01% |
69,200
-1,371,900
| -95% | -$81.3M |
|
1716
iShares Silver Trust
SLV
$20.7B
| $4.1M | ﹤0.01% |
166,700
-251,700
| -60% | -$6.18M |
|
|
CCXI
1717
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.09M | ﹤0.01% |
+66,100
| New | +$4.09M |
|
1718
Equity Bancshares
EQBK
$800M
| $4.09M | ﹤0.01% |
189,500
+8,400
| +5% | +$181K |
|
1719
iShares MSCI Japan ETF
EWJ
$15.7B
| $4.07M | ﹤0.01% |
+60,300
| New | +$4.07M |
|
1720
Orion Group Holdings
ORN
$299M
| $4.06M | ﹤0.01% |
819,363
+70,166
| +9% | +$348K |
|
1721
Akebia Therapeutics
AKBA
$782M
| $4.05M | ﹤0.01% |
1,447,927
+1,377,752
| +1,963% | +$3.86M |
|
1722
Reading International Class A
RDI
$33.8M
| $4.05M | ﹤0.01% |
805,690
-18,400
| -2% | -$92.4K |
|
1723
Mesa Laboratories
MLAB
$339M
| $4.04M | ﹤0.01% |
14,100
-28,000
| -67% | -$8.03M |
|
1724
ICU Medical
ICUI
$3.22B
| $4.03M | ﹤0.01% |
18,800
-25,000
| -57% | -$5.36M |
|
1725
Tenet Healthcare
THC
$17B
| $4.03M | ﹤0.01% |
100,975
+79,200
| +364% | +$3.16M |
|